AIA
ACAD icon

Affinity Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Affinity Investment Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,287
Closed -$291K – 126
2023
Q4 		$291K Buy
+9,287
New +$291K 0.2% 148